EP Patent

EP3150585A1 — Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity

Assigned to Parion Sciences Inc · Expires 2017-04-05 · 9y expired

What this patent protects

This invention provides chloro-pyrazine carboxamide derivatives useful as sodium channel blockers, compositions containing the same, therapeutic methods and uses for the same and processes for preparing the same.

USPTO Abstract

This invention provides chloro-pyrazine carboxamide derivatives useful as sodium channel blockers, compositions containing the same, therapeutic methods and uses for the same and processes for preparing the same.

Drugs covered by this patent

Patent Metadata

Patent number: EP3150585A1
Jurisdiction: EP
Classification: —
Expires: 2017-04-05
Drug substance claim: No
Drug product claim: No
Assignee: Parion Sciences Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.